IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Qiming U.S. Ventures Management, LLC

Q2 2024 Holdings

Filed 2024-08-13 | 6 holdings | $52.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Jasper Therapeutics Inc(JSPR)COM NEW471871202$21.1M928,96440.1%
Korro BIO Inc(KRRO)COM500946108$12.5M368,08523.7%
Tourmaline BIO Inc(TRML)COM89157D105$9.5M741,69118.1%
Hillevax IncCOM43157M102$8.1M558,92315.4%
Ventyx Biosciences Inc(VTYX)COM92332V107$952.2K412,2251.8%
Kezar Life Sciences IncCOM49372L100$497.2K828,7110.9%